Wei‐Jian Ni

机构：University of Science and Technology of China, Anhui Provincial Hospital · ORCID：0000-0002-9844-0578

发表论文 39 篇 · 总被引 1533 次 · h-index 22

代表论文

• Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms (2022 · Science Translational Medicine · 被引 305)
• Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy (2023 · Frontiers in Immunology · 被引 74)
• Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation (2022 · Kidney International · 被引 72)
• Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2‐dependent mechanism (2023 · Clinical and Translational Medicine · 被引 52)
• MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy (2021 · Frontiers in Cell and Developmental Biology · 被引 47)
• RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation (2022 · International Immunopharmacology · 被引 38)